Related references
Note: Only part of the references are listed.Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis
Michael E. Tepedino et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli
Emmanuelle Cambau et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Ocular Pharmacokinetics of Besifloxacin Following Topical Administration to Rabbits, Monkeys, and Humans
Joel W. Proksch et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Development of a Topical Polymeric Mucoadhesive Ocular Delivery System for Azithromycin
Lyle M. Bowman et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% Compared with Moxifloxacin Ophthalmic Solution 0.5% for Treating Bacterial Conjunctivitis
Marguerite B. McDonald et al.
OPHTHALMOLOGY (2009)
Survival of Donor-Derived Cells in Human Corneal Transplants
Neil Lagali et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones
M. Yamada et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty
Edward J. Holland et al.
CORNEA (2008)
Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry
Dana R. Arnold et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis
Natalie A. Afshari et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
A Comparison of Fluoroquinolone Penetration into Human Conjunctival Tissue
Makoto Aihara et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
Molecular design for enhancement of ocular penetration
Yoshihisa Shirasaki
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Management strategies for acute a infective conjunctivitis in primary care: a systematic review
Peter Rose
EXPERT OPINION ON PHARMACOTHERAPY (2007)
A novel In vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues
Geoffrey R. Owen et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model
Ramazan Yagci et al.
EYE (2007)
Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use
Keith W. Ward et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Fourth-generation fluoroquinolone penetration into the aqueous humor in humans
JP McCulley et al.
OPHTHALMOLOGY (2006)
Future in vitro and animal studies: Development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics
CH Nightingale
PHARMACOTHERAPY (2005)
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans
SM Robertson et al.
SURVEY OF OPHTHALMOLOGY (2005)
Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops
HR Koch et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2005)
Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
R Solomon et al.
OPHTHALMOLOGY (2005)
Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue
RS Wagner et al.
ARCHIVES OF OPHTHALMOLOGY (2005)
Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing
JM Levine et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
The effect of cataract surgery on ocular levels of topical moxifloxacin
R Mather et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing
JM Levine et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2004)
Evaluation and prediction of fluoroquinolone pharmacodynamics in bacterial keratitis
KR Wilhelmus
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2003)
Clinical pharmacodynamics of quinolones
PG Ambrose et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan
N Kurokawa et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2002)
Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit,and rat eyes
AA Acheampong et al.
DRUG METABOLISM AND DISPOSITION (2002)
Application of fluoroquinolone pharmacodynamics
DH Wright et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
